Breaking News: Large Study Shows Measuring Medication Risk with MedWise® Can Help Reduce Premature Death
Click to learn what these findings mean for medication safety and practice

R&D Lunch & Learn Recap

In this R&D Lunch and Learn series, Jacques Turgeon, BPharm, PhD, Chief Scientific Officer of TRHC, was interviewed by esteemed healthcare professionals about TRHC’s recent peer-reviewed research that demonstrates how pharmacist-led interventions are helping drive better outcomes for a better world.

Below we’ve provided a recap of each session for your review.

R&D Lunch and Learn - October 25, 2021

Watch our lunch and learn recap from October 25th when Jan Berger, MD, MJ, Founder, President, and CEO of Health Intelligence Partners, and Orsula V. Knowlton, PharmD, MBA, Co-founder, President, Chief Marketing and New Business Development Officer of TRHC, interviewed Jacques Turgeon, BPharm, PhD, Chief Scientific Officer of TRHC.

R&D Lunch and Learn - November 3, 2021

Watch our lunch and learn recap from November 3rd when Dr. Samira Beckwith, President and CEO of Hope Healthcare & Orsula V. Knowlton, PharmD, MBA, Co-founder, President, Chief Marketing and New Business Development Officer of TRHC, interviewed Jacques Turgeon, BPharm, PhD, Chief Scientific Officer of TRHC.

R&D Lunch and Learn - November 16, 2021

Watch our lunch and learn recap from October 25th when Jan Berger, MD, MJ, Founder, President, and CEO of Health Intelligence Partners, and Orsula V. Knowlton, PharmD, MBA, Co-founder, President, Chief Marketing and New Business Development Officer of TRHC, interviewed Jacques Turgeon, BPharm, PhD, Chief Scientific Officer of TRHC.

New Research! 4 Years in the Making!

TRHC’s multifaceted Research and Development team has compiled insights from the pharmacist-led model into three peer-reviewed articles. The results are summarized in our most recent white paper.